Inventiva S.A. (IVA)
NASDAQ: IVA · Real-Time Price · USD
4.400
+0.100 (2.33%)
At close: Jul 14, 2026, 4:00 PM EDT
4.350
-0.050 (-1.14%)
Pre-market: Jul 15, 2026, 4:19 AM EDT
Inventiva Market Cap
Inventiva has a market cap or net worth of $1.03 billion as of July 14, 2026. Its market cap has increased by 140.08% in one year.
Market Cap
1.03B
Enterprise Value
1.18B
1-Year Change
140.08%
Ranking
Category
Stock Price
$4.40
Market Cap Chart
Since July 10, 2020, Inventiva's market cap has increased from $547.96M to $1.03B, an increase of 88.49%. That is a compound annual growth rate of 11.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 1.03B | 16.72% |
| Dec 31, 2025 | 884.84M | 309.83% |
| Dec 31, 2024 | 215.91M | -7.64% |
| Dec 29, 2023 | 233.77M | 16.05% |
| Dec 30, 2022 | 201.44M | -63.07% |
| Dec 31, 2021 | 545.53M | -0.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Olema Pharmaceuticals | 1.05B |
| Forte Biosciences | 994.53M |
| Janux Therapeutics | 988.56M |
| Kura Oncology | 988.06M |
| Lexicon Pharmaceuticals | 975.01M |
| Avalo Therapeutics | 972.20M |
| Pharming Group | 970.52M |
| Vor Biopharma | 968.30M |